Australia Wants To Link Regulatory Review Of CDx And Associated Drugs
Executive Summary
Therapeutic Goods Administration proposals say the review of companion diagnostics and their corresponding drugs should be linked.
You may also be interested in...
Views Differ On Australian Proposal To Link Review Of CDx With Drugs
Australian proposal to establish a regulatory framework for companion diagnostics has drawn a mixed response from pharmaceutical, biotech and medtech companies on issues like concurrent evaluation, product classification and unique identification.
Australia Wants To Link Regulatory Review Of CDx And Associated Drugs
Therapeutic Goods Administration proposals say the review of companion diagnostics and their corresponding drugs should be linked.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.